日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Platelet-activating histone/antihistone IgG complexes in anti-PF4-negative thrombosis and thrombocytopenia syndrome.

抗 PF4 阴性血栓形成和血小板减少症综合征中的血小板激活组蛋白/抗组蛋白 IgG 复合物

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024015076
Esefeld Max, Handtke Stefan, Kaiser Rainer, Nicolai Leo, Di Fina Lea, Rossaro Dario, Wesche Jan, Rath Justina, Wienrich Ann-Christin, Hoffmann Till, Harasser Lukas, Feistritzer Clemens, Loacker Lorin, Lotfi Kourosh, Holmström Margareta, Antovic Jovan, Steil Leif, Völker Uwe, Ulm Lena, Becker Karsten, Hübner Nils Olaf, Greinacher Andreas, Thiele Thomas
免疫/内分泌
IgG
发表日期：2025
文献求助 收藏

Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint status

根据国际血栓与止血学会出血评估工具对非重型血友病患者的出血表型、出血频率和关节状态进行评估

期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2023.100047
Rejtő, Judit; Kraemmer, Daniel; Grilz, Ella; Königsbrügge, Oliver; Gabler, Cornelia; Schuster, Gerhard; Feistritzer, Clemens; Sunder-Plaßmann, Raute; Quehenberger, Peter; Ay, Cihan; Pabinger, Ingrid; Gebhart, Johanna
心血管
发表日期：2023
文献求助 收藏

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies

血液病患者对 COVID-19 疫苗的血清学反应主要在淋巴系统恶性肿瘤中受损，但在髓系恶性肿瘤中未受影响。

期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000686
Petzer, Verena; Steiner, Normann; Angelova-Unterberger, Olga; Hetzenauer, Gabriele; Philipp-Abbrederis, Kathrin; Willenbacher, Ella; Feistritzer, Clemens; Willenbacher, Wolfgang; Rudzki, Jakob; Stauder, Reinhard; Kocher, Florian; Seeber, Andreas; Pircher, Andreas; Tymoszuk, Piotr; Isara, Christian; Egger, Alexander; Fux, Vilmos; Anliker, Markus; Gunsilius, Eberhard; Nachbaur, David; Schmidt, Stefan; Wolf, Dominik
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Nonneutralizing FVIII-specific antibody signatures in patients with hemophilia A and in healthy donors

A型血友病患者和健康供体中非中和性FVIII特异性抗体特征

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021005745
Schweiger, Helmut; Rejtő, Judit; Hofbauer, Christoph J; Berg, Verena; Allacher, Peter; Zwiauer, Karl; Feistritzer, Clemens; Schuster, Gerhard; Ay, Cihan; Reipert, Birgit M; Pabinger, Ingrid
发表日期：2022
文献求助 收藏

Major cardiac surgery with recombinant FIX Fc fusion protein replacement in hemophilia B: a case report

B型血友病患者接受重组FIX Fc融合蛋白替代疗法进行重大心脏手术：病例报告

期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/20406207221104595
Bohn, Jan-Paul; Fiala, Anna; Bachmann, Sebastian; Irsara, Christian; Wolf, Dominik; Feistritzer, Clemens
发表日期：2022
文献求助 收藏

Intermittent retinal artery occlusions as the first clinical manifestation of polycythemia vera: a case report

间歇性视网膜动脉阻塞作为真性红细胞增多症的首发临床表现：病例报告

期刊:BMC Ophthalmology
影响因子:1.7
doi:10.1186/s12886-022-02423-w
Regensburger, Jasmin; Rauchegger, Teresa; Loacker, Lorin; Falkner, Florian; Feistritzer, Clemens; Teuchner, Barbara
细胞生物学
红细胞
发表日期：2022
文献求助 收藏

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.

骨髓增生性肿瘤中NETosis水平升高与血栓事件无关

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2020004061
Schmidt Stefan, Daniliants Dimitri, Hiller Elisabeth, Gunsilius Eberhard, Wolf Dominik, Feistritzer Clemens
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

罗米司亭在欧洲临床实践中治疗新诊断、持续性和慢性免疫性血小板减少症患者的有效性和安全性

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-01727-5
Snell Taylor, Sara J; Nielson, Carrie M; Breskin, Alexander; Saul, Bradley; Yu, Ying; Alam, Naufil; Eisen, Melissa; Hippenmeyer, Jane; Janssens, Ann; Kozak, Tomas; Papadaki, Helen A; Selleslag, Dominik; Viallard, Jean-Francois; Feistritzer, Clemens; Kaiafa, Georgia; Kelsh, Michael; Kilpatrick, Karynsa; Brookhart, M Alan; McGrath, Leah J
血小板
免疫/内分泌
发表日期：2021
文献求助 收藏

Bleeding outcomes and factor utilization after switching to an extended half-life product for prophylaxis in haemophilia A in Austria

奥地利A型血友病患者改用长效凝血因子制剂进行预防性治疗后的出血结局和凝血因子利用情况

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-021-92245-5
Ay, Cihan; Feistritzer, Clemens; Rettl, Joachim; Schuster, Gerhard; Vavrovsky, Anna; Perschy, Leonard; Pabinger, Ingrid
发表日期：2021
文献求助 收藏

Case report: successful perioperative management of patients with haemophilia A using an extended half-life factor VIII (Efmoroctocog alfa) during neurosurgical procedures

病例报告：在神经外科手术中使用长效半衰期因子VIII（Efmoroctocog alfa）成功进行A型血友病患者的围手术期管理

期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/2040620721993686
Kocher, Florian; Seeber, Andreas; Kerschbaumer, Johannes; Schmidt, Stefan; Wolf, Dominik; Feistritzer, Clemens
发表日期：2021
文献求助 收藏